Concussion-Recovery Trajectories Among Tactical Athletes: Results From the CARE Consortium.


Journal

Journal of athletic training
ISSN: 1938-162X
Titre abrégé: J Athl Train
Pays: United States
ID NLM: 9301647

Informations de publication

Date de publication:
01 Jul 2020
Historique:
pubmed: 20 6 2020
medline: 22 12 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Assessments of the duration of concussion recovery have primarily been limited to sport-related concussions and male contact sports. Furthermore, whereas durations of symptoms and return-to-activity (RTA) protocols encompass total recovery, the trajectory of each duration has not been examined separately. To identify individual (eg, demographics, medical history), initial concussion injury (eg, symptoms), and external (eg, site) factors associated with symptom duration and RTA-protocol duration after concussion. Cohort study. Three US military service academies. A total of 10 604 cadets at participating US military service academies enrolled in the study and completed a baseline evaluation and up to 5 postinjury evaluations. A total of 726 cadets (451 men, 275 women) sustained concussions during the study period. Number of days from injury (1) until the participant became asymptomatic and (2) to complete the RTA protocol. Varsity athlete cadets took less time than nonvarsity cadets to become asymptomatic (hazard ratio [HR] = 1.75, 95% confidence interval = 1.38, 2.23). Cadets who reported less symptom severity on the Sport Concussion Assessment Tool, third edition (SCAT3), within 48 hours of concussion had 1.45 to 3.77 times shorter symptom-recovery durations than those with more symptom severity. Similar to symptom duration, varsity status was associated with a shorter RTA-protocol duration (HR = 1.74, 95% confidence interval = 1.34, 2.25), and less symptom severity on the SCAT3 was associated with a shorter RTA-protocol duration (HR range = 1.31 to 1.47). The academy that the cadet attended was associated with the RTA-protocol duration (P < .05). The initial total number of symptoms reported and varsity athlete status were strongly associated with symptom and RTA-protocol durations. These findings suggested that external (varsity status and academy) and injury (symptom burden) factors influenced the time until RTA.

Identifiants

pubmed: 32556201
pii: 437219
doi: 10.4085/1062-6050-10-19
pmc: PMC7384467
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

658-665

Informations de copyright

© by the National Athletic Trainers' Association, Inc.

Références

Br J Sports Med. 2009 May;43 Suppl 1:i76-90
pubmed: 19433429
J Neurotrauma. 2019 Jul 1;36(13):2065-2072
pubmed: 30688141
Am J Sports Med. 2016 Jan;44(1):226-33
pubmed: 26546304
PLoS One. 2019 May 1;14(5):e0215030
pubmed: 31042725
Clin J Sport Med. 2004 Nov;14(6):339-43
pubmed: 15523205
Orthop J Sports Med. 2018 Mar 14;6(3):2325967118760854
pubmed: 29568786
J Neurosurg Pediatr. 2014 Jan;13(1):72-81
pubmed: 24206343
Am J Sports Med. 2010 Mar;38(3):464-71
pubmed: 20194953
J Am Acad Orthop Surg. 2017 Dec;25(12):818-828
pubmed: 29176505
J Emerg Med. 2005 Aug;29(2):189-97
pubmed: 16029831
J Pediatr. 2016 Jul;174:33-38.e2
pubmed: 27056449
Br J Sports Med. 2017 Jun;51(11):848-850
pubmed: 28446453
Neurosurgery. 2014 Sep;75 Suppl 1:S3-15
pubmed: 25006974
Am J Sports Med. 2016 Nov;44(11):2941-2946
pubmed: 27371548
Clin J Sport Med. 2016 Jan;26(1):33-9
pubmed: 25894530
Clin J Sport Med. 2017 May;27(3):321-324
pubmed: 27437911
Am J Sports Med. 2011 Nov;39(11):2311-8
pubmed: 21712482
J Athl Train. 2016 Mar;51(3):189-94
pubmed: 26950073
Arch Clin Neuropsychol. 2020 Apr 20;35(3):291-301
pubmed: 30796799
Sports Med. 2017 Jul;47(7):1437-1451
pubmed: 28281095
J Int Neuropsychol Soc. 2013 Jan;19(1):22-33
pubmed: 23058235
Pediatrics. 2013 Jul;132(1):8-17
pubmed: 23753087
Br J Sports Med. 2017 Jun;51(11):838-847
pubmed: 28446457
J Sport Health Sci. 2018 Apr;7(2):204-209
pubmed: 30356457
Neurology. 2016 May 17;86(20):1856-63
pubmed: 27164666
Am J Sports Med. 2000 Sep-Oct;28(5):643-50
pubmed: 11032218
J Neurotrauma. 2018 Jan 15;35(2):249-259
pubmed: 29017409
J Athl Train. 2018 Nov;53(11):1017-1024
pubmed: 30403363
J Pediatr Psychol. 2012 Jul;37(6):650-9
pubmed: 22451261
Br J Sports Med. 2017 Jun;51(12):941-948
pubmed: 28566342
Ann Biomed Eng. 2012 Jan;40(1):106-13
pubmed: 21997390

Auteurs

Kathryn L Van Pelt (KL)

NeuroTrauma Research Laboratory, University of Michigan, Ann Arbor.

C Dain Allred (CD)

United States Air Force Academy, CO.

Rachel Brodeur (R)

US Coast Guard Academy, New London, CT.

Kenneth L Cameron (KL)

John A. Feagin Jr. Sports Medicine Fellowship, Keller Army Community Hospital, West Point, NY.

Darren E Campbell (DE)

Brigham Young University, Provo, UT.

Christopher J D'Lauro (CJ)

United States Air Force Academy, CO.

Xuming He (X)

Department of Statistics, University of Michigan, Ann Arbor.

Megan N Houston (MN)

John A. Feagin Jr. Sports Medicine Fellowship, Keller Army Community Hospital, West Point, NY.

Brian R Johnson (BR)

United States Air Force Academy, CO.

Tim F Kelly (TF)

Department of Intercollegiate Athletics, United States Military Academy at West Point, NY.

Gerald McGinty (G)

United States Air Force Academy, CO.

Sean K Meehan (SK)

University of Waterloo, ON, Canada.

Patrick G O'Donnell (PG)

US Coast Guard Academy, New London, CT.

Karen Y Peck (KY)

John A. Feagin Jr. Sports Medicine Fellowship, Keller Army Community Hospital, West Point, NY.

Steven J Svoboda (SJ)

MedStar, Washington, DC.

Paul Pasquina (P)

Department of Rehabilitation Medicine, Walter Reed National Military Medical Center, Uniformed Services University of the Health Sciences, Bethesda, MD.

Thomas McAllister (T)

Indiana University School of Medicine, Indianapolis.

Michael McCrea (M)

Medical College of Wisconsin, Milwaukee. Dr Van Pelt is now at the Sanders-Brown Center on Aging, University of Kentucky.

Steven P Broglio (SP)

NeuroTrauma Research Laboratory, University of Michigan, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH